Molecular characterization of pro-metastatic functions of &#x03B2;4-integrin in colorectal cancer

Wanguang Zhang; Bixiang Zhang; Trung Vu; Guandou Yuan; Binhao Zhang; Xiaoping Chen; Upender Manne; Pran K. Datta

doi:10.18632/oncotarget.21290

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer

Wanguang Zhang, Bixiang Zhang, Trung Vu, Guandou Yuan, Binhao Zhang, Xiaoping Chen, Upender Manne and Pran K. Datta _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:92333-92345. https://doi.org/10.18632/oncotarget.21290

Metrics: PDF 1694 views | HTML 2721 views | ?

Abstract

Wanguang Zhang1,3,*, Bixiang Zhang1,3,*, Trung Vu2, Guandou Yuan1,2,4, Binhao Zhang1,3, Xiaoping Chen3, Upender Manne5 and Pran K. Datta1,2

1Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA

2Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA

3Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

4Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China

5Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

*These authors have contributed equally to this work

Correspondence to:

Pran K. Datta, email: [email protected]

Keywords: colorectal cancer, liver metastasis, affymetrix microarray, β4-integrin, tissue microarray

Received: February 25, 2017 Accepted: August 15, 2017 Published: September 27, 2017

ABSTRACT

The β4-integrin subunit has been implicated in development and progression of several epithelial tumor types. However, its role in metastases of colorectal cancer (CRC) remains elusive. To study CRC metastasis, we generated a highly invasive, metastatic cell line MC38-LM10 (LM10) by passaging mouse CRC MC38 cells ten times, using a splenic injection model of liver metastasis. Affymetrix microarray analyses of LM10 and MC38 cell lines and their corresponding liver metastases generated a gene signature for CRC metastasis. This signature shows strong upregulation of β4-integrin in LM10 cells and corresponding metastases. Upregulation of β4-integrin in highly aggressive LM10 cells is associated with increased migration, invasion, and liver metastases. Furthermore, stable knockdown of β4-integrin in human CRC SW620 cells reduces Bcl-2 expression, increases apoptosis, and decreases invasion, tumorigenicity, and liver metastasis, thus resulting in significantly increased survival of mice (hazard ratio = 0.32, 95% confidence interval = 0.15-0.66, P<0.01). Patients with CRC tumors display higher β4-integrin levels in stages 1-4 and significantly lower survival rate. Collectively, β4-integrin plays a critical role in CRC progression, invasion, and metastasis, suggesting that it could be a potential therapeutic target for CRC patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21290

Publication Alerts

Research Papers:

Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer

Abstract